Abbott Laboratories Stock (NYSE:ABT)


ForecastRevenueOwnershipFinancialsChartTranscripts

Previous Close

$113.64

52W Range

$89.67 - $121.64

50D Avg

$111.98

200D Avg

$110.04

Market Cap

$195.27B

Avg Vol (3M)

$6.03M

Beta

0.72

Div Yield

$2.20 (1.92%)

ABT Company Profile


Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. The Diagnostic Products segment offers laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and measure infectious agents; point of care systems; cartridges for testing blood; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. The Nutritional Products segment provides pediatric and adult nutritional products. The Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; and diabetes care products, as well as neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.

Show More

Industry

Medical - Devices

Sector

Healthcare

Exchange

NYSE

ADR

-

Country

US

Employees

114,000

IPO Date

Mar 17, 1980

Website

ABT Performance


Revenue Breakdown


Revenue Breakdown by Product/Service

Product/ServiceDec 23Dec 22Dec 21
Established Pharmaceutical Products$5.07B$4.91B$4.72B
Medical Devices$16.89B$14.69B$435.00M
Nutritional Products$8.15B$7.46B$8.29B
Diagnostic Products$9.99B$16.58B$4.00B

Fiscal year ends in Dec 23 | Currency in USD

ABT Financial Summary


Dec 23Dec 22Dec 21
Revenue$40.11B$43.65B$43.08B
Operating Income$6.69B$8.36B$8.43B
Net Income$5.72B$6.93B$7.07B
EBITDA$9.93B$10.70B$10.75B
Basic EPS$3.26$3.91$4.01
Diluted EPS$3.27$3.88$3.94

Fiscal year ends in Dec 23 | Currency in USD

Latest Earnings Call Transcripts


Q2 24Jul 18, 24 | 12:40 PM
Q1 24Apr 17, 24 | 12:05 PM
Q4 23Jan 24, 24 | 12:00 AM

Peer Comparison


TickerCompany
LLYEli Lilly and Company
ABBVAbbVie Inc.
MDTMedtronic plc
JNJJohnson & Johnson
BMYBristol-Myers Squibb Company